Table 6.
aStatistically significant difference between arms.
bMedian OS not reached in either arm.
cMajor AEs/AEs that differ between arms.
Abbreviations: AE, adverse event; CR, complete response; GI, gastrointestinal; MP, melphalan plus prednisone; NA, not available; OS, overall survival; PFS, progression-free survival; PN, peripheral neuropathy; PR, partial response; TTP, time to progression; VMP, bortezomib, melphalan, and prednisone; VMPT, bortezomib, melphalan, prednisone, and thalidomide; VTP, bortezomib, thalidomide, and prednisone.